KenChowder
I only have one more post for the say so I will try to address both of your points - from my perspective. My perspective if from having worked more than 25 years in the pharma Industry including at Pfizer when they bought our company. Also please realize that I have too many shares of CYDY and think the price should be much higher which is why I am holding and telling those I convince to buy the stock to do the same.
We are too focused on these message boards about conspiracy theories - that the company leaders don’t support.
The facts are that our clinical trials did not yield results that justify full approval. I was hopeful that EUA with a commitment to complete a trial in x period of time would be granted but it was not. We can’t complain about the poor approval process for REM, HYDROXY, and plasma and them jump and down and say the fda should do the same thing for CYDY. With the same data for months no other FIRST world regulatory body has approved this either for COVID or HIV. This should tell us all something as these countries have the same or worse situation vs. the US.
As far as Pfizer actively blocking this to allow us to get booster shots that is a stretch as well. I would not hesitate to get a booster shot when it is available because I want to prevent getting COVID and then progressing to severe and hoping that I am one of the people LL saved and Pfizer’s marketing team will likely view the competition to be Moderna and not CYDY.
I am hopeful but realistic about our chances for EUA in the US - which I view as extremely low with the current data.
If a congressional subcommittee where to investigate this situation they would depose the CEO who would likely say there was no issue - investigation closed.
I have been thinking that every quarter since 2017 would be the golden quarter and we have heard so many forward looking statements on the HIV BLA that CYDY had all we needed to answer the open questions that we had a real good understanding of. We are more than a year after the RTF and we are hopefully going to submit the CMC section in June - the big problem was the clinical section and they keep sidestepping the question on when that will finally be ready.
I have been quiet lately but am really frustrated and mad that we precipitated the 30% decline in stock price due to the fda feeling they had to respond to all the pestering
LL still binds to CCR5 and is safe so I still expect us to have our day in the US but we need to challenge our CYDY team to get us there and not fight the FDA.
All IMO
I only have one more post for the say so I will try to address both of your points - from my perspective. My perspective if from having worked more than 25 years in the pharma Industry including at Pfizer when they bought our company. Also please realize that I have too many shares of CYDY and think the price should be much higher which is why I am holding and telling those I convince to buy the stock to do the same.
We are too focused on these message boards about conspiracy theories - that the company leaders don’t support.
The facts are that our clinical trials did not yield results that justify full approval. I was hopeful that EUA with a commitment to complete a trial in x period of time would be granted but it was not. We can’t complain about the poor approval process for REM, HYDROXY, and plasma and them jump and down and say the fda should do the same thing for CYDY. With the same data for months no other FIRST world regulatory body has approved this either for COVID or HIV. This should tell us all something as these countries have the same or worse situation vs. the US.
As far as Pfizer actively blocking this to allow us to get booster shots that is a stretch as well. I would not hesitate to get a booster shot when it is available because I want to prevent getting COVID and then progressing to severe and hoping that I am one of the people LL saved and Pfizer’s marketing team will likely view the competition to be Moderna and not CYDY.
I am hopeful but realistic about our chances for EUA in the US - which I view as extremely low with the current data.
If a congressional subcommittee where to investigate this situation they would depose the CEO who would likely say there was no issue - investigation closed.
I have been thinking that every quarter since 2017 would be the golden quarter and we have heard so many forward looking statements on the HIV BLA that CYDY had all we needed to answer the open questions that we had a real good understanding of. We are more than a year after the RTF and we are hopefully going to submit the CMC section in June - the big problem was the clinical section and they keep sidestepping the question on when that will finally be ready.
I have been quiet lately but am really frustrated and mad that we precipitated the 30% decline in stock price due to the fda feeling they had to respond to all the pestering
LL still binds to CCR5 and is safe so I still expect us to have our day in the US but we need to challenge our CYDY team to get us there and not fight the FDA.
All IMO
12
